A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects
Conditions
- Nonalcoholic Steatohepatitis (NASH)
Interventions
- DRUG: XZP-5610 Tablet (for Part A)
- DRUG: Placebo to match XZP-5610 Tablet (for Part A)
- DRUG: XZP-5610 Tablet (for Part B)
- DRUG: Placebo to match XZP-5610 Tablet (for Part B)
- DRUG: XZP-5610 Tablet (for "Part C1")
- DRUG: XZP-5610 Tablet for "Part C2"
Sponsor
Xuanzhu Biopharmaceutical Co., Ltd.